Tag #Obesity

Showing 85 to 96 of 118 results

dailymail.co.uk

🌐 85% Global Worthiness

Dec 19, 13:11

Children's Heart Health Declines at Age 10, Increasing Adult Disease Risk

Research reveals that children's heart health begins deteriorating around age 10 due to poor lifestyle choices, increasing their risk of heart attacks and strokes as adults; the study involved over 1,500 children aged 3-16 in Massachusetts.

Children's Heart Health Declines at Age 10, Increasing Adult Disease Risk

Research reveals that children's heart health begins deteriorating around age 10 due to poor lifestyle choices, increasing their risk of heart attacks and strokes as adults; the study involved over 1,500 children aged 3-16 in Massachusetts.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors contribute to the decline in cardiovascular health around age 10, and how do these factors relate to broader societal trends?

This decline correlates with lifestyle changes, such as less healthy eating and sleep, often coinciding with the transition to secondary school. The study highlights the importance of healthy habits during mid-childhood and early adolescence to mitigate future cardiovascular risks. Globally, childhood obesity is a growing concern, with 37 million children under five now overweight.

nrc.nl

🌐 85% Global Worthiness

Dec 16, 22:09

Dutch Council Urges Fines for Supermarkets Selling Unhealthy Food

The Dutch Health Council advises the government to fine supermarkets selling too much unhealthy food and reward those promoting healthier options at checkout, aiming to curb rising obesity rates projected to affect 64% of the population by 2050.

Dutch Council Urges Fines for Supermarkets Selling Unhealthy Food

The Dutch Health Council advises the government to fine supermarkets selling too much unhealthy food and reward those promoting healthier options at checkout, aiming to curb rising obesity rates projected to affect 64% of the population by 2050.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What immediate actions does the RVS recommend to combat the rising rates of obesity and related health issues in the Netherlands?

The Dutch Health Council (RVS) urges the government to fine supermarkets selling excessive unhealthy food and reward those promoting healthier options near checkout counters. This follows research indicating that 64 percent of the Dutch population could be overweight by 2050 if no changes are implemented, resulting in 13,000 deaths and €6 billion in avoidable healthcare costs annually.

lexpansion.lexpress.fr

🌐 75% Global Worthiness

Dec 9, 22:09

France Approves Wegovy Reimbursement for Severely Obese Adults

France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.

France Approves Wegovy Reimbursement for Severely Obese Adults

France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of France's decision to reimburse Wegovy for severely obese patients?

France will now reimburse Wegovy, a weight-loss injection, for severely obese adults (BMI ≥35 kg/m²) needing additional support. The drug, costing €274-365 monthly, requires a low-calorie diet and increased physical activity. This follows a positive review by the HAS, incorporating new data showing reduced cardiovascular risks.

cnnespanol.cnn.com

🌐 85% Global Worthiness

Dec 6, 07:09

US Life Expectancy to Increase Minimally by 2050, Lagging Behind Other Nations

A new study projects a small increase in US life expectancy to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdoses, and other health risks, highlighting the need for improved health policies.

US Life Expectancy to Increase Minimally by 2050, Lagging Behind Other Nations

A new study projects a small increase in US life expectancy to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdoses, and other health risks, highlighting the need for improved health policies.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the projected change in US life expectancy by 2050, and what are the primary factors contributing to this projection?

The US life expectancy is projected to increase only slightly from 78.3 years in 2022 to 80.4 years by 2050, according to a new study by the Institute for Health Metrics and Evaluation (IHME). This minimal improvement highlights alarming health challenges facing the nation. The US will lag behind most other high-income and some middle-income nations in life expectancy gains, falling from 49th to 66th place globally by 2050.

theguardian.com

🌐 75% Global Worthiness

Dec 5, 10:08

England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug

The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.

England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug

The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the NHS manage the demand for Mounjaro, given its high cost and limited initial availability?

NICE prioritizes patients with the highest clinical needs, primarily those receiving care from specialist weight management services. This phased rollout aims to balance the benefits of Mounjaro—shown to cause 20.2% weight loss in trials—with the financial burden on the NHS. The 12-year plan, requested by NHS England, allows for a review in three years to assess the drug's impact and adjust the rollout accordingly.

us.cnn.com

🌐 85% Global Worthiness

Dec 4, 19:08

Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial

A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.

Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial

A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the key difference in weight loss outcomes between Zepbound and Wegovy in this clinical trial?

In a head-to-head clinical trial, adults using Zepbound (tirzepatide) achieved 47% greater weight loss than those using Wegovy (semaglutide) after about 18 months. This translates to an average weight loss of 50 pounds for Zepbound users versus 33 pounds for Wegovy users.

kathimerini.gr

🌐 85% Global Worthiness

Dec 17, 22:11

Greece Launches New Obesity Drug Amidst Booming Market

Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.

Greece Launches New Obesity Drug Amidst Booming Market

Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the new obesity drug, tirzepatide, on the Greek healthcare market and patient access?

A new injectable drug, tirzepatide, has launched in Greece, costing \"253.05 EUR\" per dose and promising at least \"20%\" weight loss. High demand is anticipated, with initial stock potentially depleted by January. This launch reflects a booming obesity treatment market projected to reach \"200 billion USD\" by 2030.

euronews.com

🌐 75% Global Worthiness

Dec 9, 16:11

Ultra-Processed Foods Linked to Increased Thigh Muscle Fat

A study of 666 individuals found a correlation between higher ultra-processed food consumption and increased intramuscular thigh fat, regardless of calorie intake, BMI, or activity levels, suggesting a direct impact on muscle health and potentially conditions like osteoarthritis and type 2 diabetes.

Ultra-Processed Foods Linked to Increased Thigh Muscle Fat

A study of 666 individuals found a correlation between higher ultra-processed food consumption and increased intramuscular thigh fat, regardless of calorie intake, BMI, or activity levels, suggesting a direct impact on muscle health and potentially conditions like osteoarthritis and type 2 diabetes.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this study's use of MRI and the NOVA food classification contribute to our understanding of the link between diet quality and musculoskeletal health?

The study, using the NOVA food classification and MRI, shows that higher UPF consumption correlates with increased intramuscular fat. This finding expands our understanding of UPF's effects beyond obesity, highlighting its potential role in musculoskeletal health issues.

cnn.com

🌐 85% Global Worthiness

Dec 6, 07:09

US Life Expectancy to Rise Minimally, Lagging Behind Other Nations

US life expectancy is projected to increase minimally to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdose deaths, and other health risks; this will drop the US to 66th globally in life expectancy rankings from 49th in 2022.

US Life Expectancy to Rise Minimally, Lagging Behind Other Nations

US life expectancy is projected to increase minimally to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdose deaths, and other health risks; this will drop the US to 66th globally in life expectancy rankings from 49th in 2022.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key factors contributing to the slow improvement in US life expectancy?

Rising obesity rates, projected to affect over 260 million Americans by 2050, pose a major public health crisis, contributing to the slow improvement in life expectancy. High rates of drug overdose deaths, twice as high as in Canada, further impede progress despite recent declines. These factors contribute to the US's declining global life expectancy ranking.

edition.cnn.com

🌐 85% Global Worthiness

Dec 5, 22:09

Belly Fat Linked to Early Alzheimer's Biomarkers

Research reveals a strong correlation between increased visceral abdominal fat and the presence of amyloid plaques and tau tangles in the brain, key Alzheimer's biomarkers, even before cognitive decline is evident; reducing belly fat may be a crucial preventative strategy.

Belly Fat Linked to Early Alzheimer's Biomarkers

Research reveals a strong correlation between increased visceral abdominal fat and the presence of amyloid plaques and tau tangles in the brain, key Alzheimer's biomarkers, even before cognitive decline is evident; reducing belly fat may be a crucial preventative strategy.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does visceral fat differ from subcutaneous fat in its contribution to Alzheimer's risk?

The study, using MRI and PET scans, found a correlation between higher visceral fat levels and increased levels of both amyloid and tau in the brain. This connection appears decades before typical Alzheimer's symptom onset, highlighting visceral fat as a significant risk factor.

abcnews.go.com

🌐 85% Global Worthiness

Dec 4, 16:09

Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial

A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...

Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial

A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How much more effective is Zepbound compared to Wegovy in facilitating weight loss within a 72-week timeframe, and what are the specific weight loss differences observed?

A new, Eli Lilly-funded study reveals that Zepbound, containing tirzepatide, yielded 20% weight loss in obese or overweight individuals over 72 weeks—significantly more than Wegovy's under 14% weight loss. This translates to roughly 50 pounds lost with Zepbound versus 33 pounds with Wegovy. The study, however, is yet to undergo peer review.

dailymail.co.uk

🌐 75% Global Worthiness

Dec 4, 07:09

UK Junk Food Ad Ban: Minimal Impact Projected

The UK government banned junk food advertising online and before 9pm on TV starting October 2024 to combat childhood obesity; however, the projected impact is minimal, reducing children's daily calorie intake by only 2.1 calories.

UK Junk Food Ad Ban: Minimal Impact Projected

The UK government banned junk food advertising online and before 9pm on TV starting October 2024 to combat childhood obesity; however, the projected impact is minimal, reducing children's daily calorie intake by only 2.1 calories.

Progress

68% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

What are the broader societal factors contributing to childhood obesity beyond advertising?

This ban is part of a broader trend of government intervention to address health concerns, reflecting a societal shift towards greater regulation of food marketing. However, the minimal impact of this specific ban highlights the complexity of the obesity problem and the need for a more holistic approach.

Showing 85 to 96 of 118 results